BOSTON SCIENTIFIC CORP — Director's Dealing 2021

Jun 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-06-14

Reporting Person: Monson Jonathan (VP, Global Controller and CAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-14	Common Stock	M	5000.0000	$13.0800	Acquired	42062.0000	Direct
2021-06-14	Common Stock	S	5000.0000	$42.9400	Disposed	37062.0000	Direct
2021-06-15	Common Stock	M	7901.0000	$12.8900	Acquired	44963.0000	Direct
2021-06-15	Common Stock	S	7901.0000	$42.7842	Disposed	37062.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-14	Stock Option (Right to Buy)	$13.0800	M	5000.0000	Disposed	2024-02-24	Common Stock (5000.0000)	Direct
2021-06-15	Stock Option (Right to Buy)	$12.8900	M	7901.0000	Disposed	2024-12-01	Common Stock (7901.0000)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.

F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.63 to $42.93, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Grant to the reporting person on February 24, 2014, of an option to purchase 15,000 shares of common stock.

F4: Grant to the reporting person on December 1, 2014, of an option to purchase 17,901 shares of common stock.